NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

This press release is being prepared.

The market announcement is already indexed, but the document has not finished syncing to our storage yet.